Literature DB >> 19770509

A new crystal form of human tear lipocalin reveals high flexibility in the loop region and induced fit in the ligand cavity.

Daniel A Breustedt1, Lorenz Chatwell, Arne Skerra.   

Abstract

Tear lipocalin (TLC) with the bound artificial ligand 1,4-butanediol has been crystallized in space group P2(1) with four protein molecules in the asymmetric unit and its X-ray structure has been solved at 2.6 A resolution. TLC is a member of the lipocalin family that binds ligands with diverse chemical structures, such as fatty acids, phospholipids and cholesterol as well as microbial siderophores and the antibiotic rifampin. Previous X-ray structural analysis of apo TLC crystallized in space group C2 revealed a rather large bifurcated ligand pocket and a partially disordered loop region at the entrace to the cavity. Analysis of the P2(1) crystal form uncovered major conformational changes (i) in beta-strands B, C and D, (ii) in loops 1, 2 and 4 at the open end of the beta-barrel and (iii) in the extended C-terminal segment, which is attached to the beta-barrel via a disulfide bridge. The structural comparison indicates high conformational plasticity of the loop region as well as of deeper parts of the ligand pocket, thus allowing adaptation to ligands that differ vastly in size and shape. This illustrates a mechanism for promiscuity in ligand recognition which may also be relevant for some other physiologically important members of the lipocalin protein family.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19770509      PMCID: PMC2756164          DOI: 10.1107/S0907444909031011

Source DB:  PubMed          Journal:  Acta Crystallogr D Biol Crystallogr        ISSN: 0907-4449


  37 in total

1.  The Protein Data Bank.

Authors:  H M Berman; J Westbrook; Z Feng; G Gilliland; T N Bhat; H Weissig; I N Shindyalov; P E Bourne
Journal:  Nucleic Acids Res       Date:  2000-01-01       Impact factor: 16.971

2.  A number of real-space torsion-angle refinement techniques for proteins, nucleic acids, ligands and solvent.

Authors:  T J Oldfield
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2001-01

Review 3.  Experimentally determined lipocalin structures.

Authors:  D R Flower
Journal:  Biochim Biophys Acta       Date:  2000-10-18

Review 4.  The bacterial lipocalins.

Authors:  R E Bishop
Journal:  Biochim Biophys Acta       Date:  2000-10-18

5.  Ligand preference inferred from the structure of neutrophil gelatinase associated lipocalin.

Authors:  D H Goetz; S T Willie; R S Armen; T Bratt; N Borregaard; R K Strong
Journal:  Biochemistry       Date:  2000-02-29       Impact factor: 3.162

Review 6.  Human tear lipocalin.

Authors:  B Redl
Journal:  Biochim Biophys Acta       Date:  2000-10-18

Review 7.  Lipocalins as a scaffold.

Authors:  A Skerra
Journal:  Biochim Biophys Acta       Date:  2000-10-18

8.  Complexes of porcine odorant binding protein with odorant molecules belonging to different chemical classes.

Authors:  F Vincent; S Spinelli; R Ramoni; S Grolli; P Pelosi; C Cambillau; M Tegoni
Journal:  J Mol Biol       Date:  2000-06-30       Impact factor: 5.469

9.  Binding studies of tear lipocalin: the role of the conserved tryptophan in maintaining structure, stability and ligand affinity.

Authors:  O K Gasymov; A R Abduragimov; T N Yusifov; B J Glasgow
Journal:  Biochim Biophys Acta       Date:  1999-08-17

10.  Molecular cloning of a novel lipocalin-1 interacting human cell membrane receptor using phage display.

Authors:  P Wojnar; M Lechner; P Merschak; B Redl
Journal:  J Biol Chem       Date:  2001-04-03       Impact factor: 5.157

View more
  20 in total

Review 1.  Focus on molecules: tear lipocalin.

Authors:  Ben J Glasgow; Oktay K Gasymov
Journal:  Exp Eye Res       Date:  2010-08-21       Impact factor: 3.467

2.  Excited protein states of human tear lipocalin for low- and high-affinity ligand binding revealed by functional AB loop motion.

Authors:  Oktay K Gasymov; Adil R Abduragimov; Ben J Glasgow
Journal:  Biophys Chem       Date:  2010-04-09       Impact factor: 2.352

3.  Effect of short- and long-range interactions on trp rotamer populations determined by site-directed tryptophan fluorescence of tear lipocalin.

Authors:  Oktay K Gasymov; Adil R Abduragimov; Ben J Glasgow
Journal:  PLoS One       Date:  2013-10-28       Impact factor: 3.240

Review 4.  The international workshop on meibomian gland dysfunction: report of the subcommittee on tear film lipids and lipid-protein interactions in health and disease.

Authors:  Kari B Green-Church; Igor Butovich; Mark Willcox; Douglas Borchman; Friedrich Paulsen; Stefano Barabino; Ben J Glasgow
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-03-30       Impact factor: 4.799

5.  pH-Dependent conformational changes in tear lipocalin by site-directed tryptophan fluorescence.

Authors:  Oktay K Gasymov; Adil R Abduragimov; Ben J Glasgow
Journal:  Biochemistry       Date:  2010-01-26       Impact factor: 3.162

6.  Cation-π interactions in lipocalins: structural and functional implications.

Authors:  Oktay K Gasymov; Adil R Abduragimov; Ben J Glasgow
Journal:  Biochemistry       Date:  2012-03-28       Impact factor: 3.162

Review 7.  Tear lipocalin: structure and function.

Authors:  Darlene A Dartt
Journal:  Ocul Surf       Date:  2011-07       Impact factor: 5.033

8.  Exploring protein solution structure: Second moments of fluorescent spectra report heterogeneity of tryptophan rotamers.

Authors:  Oktay K Gasymov; Adil R Abduragimov; Ben J Glasgow
Journal:  Spectrochim Acta A Mol Biomol Spectrosc       Date:  2015-06-19       Impact factor: 4.098

9.  The conserved disulfide bond of human tear lipocalin modulates conformation and lipid binding in a ligand selective manner.

Authors:  Oktay K Gasymov; Adil R Abduragimov; Ben J Glasgow
Journal:  Biochim Biophys Acta       Date:  2011-04-03

10.  Ligand binding complexes in lipocalins: Underestimation of the stoichiometry parameter (n).

Authors:  Ben J Glasgow; Adil R Abduragimov
Journal:  Biochim Biophys Acta Proteins Proteom       Date:  2018-07-07       Impact factor: 3.036

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.